We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid PCR Immunoassay Developed for Malaria Diagnosis

By LabMedica International staff writers
Posted on 29 Aug 2012
A polymerase chain reaction (PCR) immunoassay has been developed that detects the different malaria species and differentiates between Plasmodium falciparum and P. More...
vivax.

The test, which combines PCR with a nucleic acid lateral flow immunoassay (PCR-NALFIA) for amplicon detection, was thoroughly evaluated for the analytical sensitivity and specificity in the laboratory, the robustness, and reproducibility in a ring trial and accuracy and predictive value in a field trial.

Investigators at the Royal Tropical Institute (Amsterdam, The Netherlands) developed a PCR-NALFIA and tested its validity by analyzing 241 malaria positive and negative samples from travelers returning from malaria-endemic areas and samples provided by the Dutch blood bank considered negative for malaria. Also tested was a blood sample from Sudanese patients with a confirmed P. falciparum infection. Accuracy was evaluated in Thailand and compared to expert microscopy and rapid diagnostic tests (RDTs). A nitrocellulose membrane of 120 mm (Millipore, Amsterdam, The Netherlands) was used for the preparation of the NALFIA.

The analytical sensitivity and specificity were very high, but were slightly less sensitive for the detection of P. vivax than for P. falciparum. The reproducibility tested in three laboratories was very good, though this evaluation showed that the PCR machine used could influence the results. In the field trial in Thailand, the overall and P. falciparum-specific sensitivity and specificity was good ranging from 0.86-1 and 0.95-0.98 respectively, compared to microscopy. P. vivax detection was better than the sensitivity of RDT, but slightly less than microscopy performed in this study.

The authors concluded that the assay in its current format, or slightly modified with more sensitive detection of P. vivax, could be an excellent tool for epidemiological studies on prevalence or distribution of parasites. In addition, it could be used as a screening tool at regional level for malaria control programs, especially in countries with declining transmission. Molecular tools have been shown to be especially valuable in areas where there is moderate to little transmission and PCR-NALFIA could be a usable simple method in these settings. The study was published on August 17, 2012, in the Malaria Journal.

Related Links:

Royal Tropical Institute
Millipore



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers identified eight new DNA pattern signatures that could help refine diagnostics and guide targeted therapy in breast cancer (image credit: 123RF)

Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.